Literature DB >> 15488558

Normal variants in [18F]-fluorodeoxyglucose PET imaging.

Ghassan El-Haddad1, Abass Alavi, Ayse Mavi, Gonca Bural, Hongming Zhuang.   

Abstract

The number of fluorodeoxyglucose PET applications is increasing. In the process of reading fluorodeoxyglucose-PET scans, nuclear medicine physicians encounter a wide variety of normal findings, which must be recognized to determine the best management for patients. It is important to recognize and understand normal variants to avoid misinterpretation of more serious pathology. This article reviews different patterns of physiologic fluorodeoxyglucose uptake including changes with age.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15488558     DOI: 10.1016/j.rcl.2004.07.003

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  7 in total

1.  Pretreatment with diphenoxylate hydrochloride/atropine sulfate (Lomotil) does not decrease physiologic bowel FDG activity on PET/CT scans of the abdomen and pelvis.

Authors:  Robert Murphy; Kirk M Doerger; Mark A Nathan; Val J Lowe
Journal:  Mol Imaging Biol       Date:  2008-11-27       Impact factor: 3.488

2.  Diagnostic performance of real-time robotic arm-assisted 18F-FDG PET/CT-guided percutaneous biopsy in metabolically active abdominal and pelvic lesions.

Authors:  Rajender Kumar; Bhagwant Rai Mittal; Anish Bhattacharya; Harmandeep Singh; Amanjit Bal; Shelvin Kumar Vadi; Ashwani Sood; Gaurav Prakash; Harjeet Singh; Aman Sharma
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-08-30       Impact factor: 9.236

3.  FDG-PET/CT in lymphoma.

Authors:  Maria M D'souza; Abhinav Jaimini; Abhishek Bansal; Madhavi Tripathi; Rajnish Sharma; Anupam Mondal; Rajendra Prashad Tripathi
Journal:  Indian J Radiol Imaging       Date:  2013-10

4.  FDG-PET/CT pitfalls in oncological head and neck imaging.

Authors:  Bela S Purohit; Angeliki Ailianou; Nicolas Dulguerov; Christoph D Becker; Osman Ratib; Minerva Becker
Journal:  Insights Imaging       Date:  2014-08-26

5.  Ex vivo Measurement of the Radioactivity of PET/CT-Guided Biopsy Specimen: Is it Helpful to Confirm the Sampling from a Viable Region of the Tumor and the Nature of the Lesion?

Authors:  Navjot Kaur; Rajender Kumar; Nivedita Rana; Venkata Subramanian Krishnaraju; Bhagwant Rai Mittal
Journal:  Indian J Nucl Med       Date:  2022-07-08

Review 6.  FDG PET/CT in carcinoma of unknown primary.

Authors:  Thomas C Kwee; Sandip Basu; Gang Cheng; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-10-31       Impact factor: 9.236

7.  Evaluation of the diagnostic efficacy of 18 F-Fluorine-2-Deoxy-D-Glucose PET/CT for lung cancer and pulmonary tuberculosis in a Tuberculosis-endemic Country.

Authors:  Alexandre Niyonkuru; Xiaomin Chen; Khamis Hassan Bakari; Dilani Neranjana Wimalarathne; Altine Bouhari; Maher Mohamad Rajab Arnous; Xiaoli Lan
Journal:  Cancer Med       Date:  2019-12-13       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.